The 21 references in paper A. Brovkina F., Ye. Grishina Ye., O. Yatsenko Yu., A. Andreichenko M., А. Бровкина Ф., Е. Гришина Е., О. Яценко Ю., А. Андрейченко М. (2015) “ПЕРВЫЙ ОПЫТ ЛЕЧЕНИЯ ИНГАРОНОМ МЕЛАНОМЫ КОНЪЮНКТИВЫ // THE FIRST EXPERIENCE WITH INGARON TREATMENT FOR CONJUNCTIVAL MELANOMA” / spz:neicon:ogsh:y:2012:i:2:p:9-12

1
Абрамов М.Е., Гуторов С.Л., Славина Е.Г. и др. Химиотерапия диссеминированной меланомы кожи с включением ингарона. Клинико-иммунологические исследования. Российский биотерапевтический журнал 2009;1:64−74.
(check this in PDF content)
2
Абрамов М.Е., Кадагидзе З.Г., Славина Е.Г. Ингарон (Интерферонгамма) в сочетании с химиотерапией в лечении онкологических больных. Фарматека 2006;11:38−44.
(check this in PDF content)
3
Бровкина А.Ф. Офтальмоонкология. М.: Медицина, 2002. 421 с.
(check this in PDF content)
4
Киселевский М.В. Иммунотерапия злокачественных опухолей. Вместе против рака 2005;3:8.
(check this in PDF content)
5
Козлов В.А., Черных Е.Р. Современные проблемы иммунотерапии в онкологии. Бюллетень СО РАМН 2004;112(2):113−9.
(check this in PDF content)
6
Cagini C., Menduno P., Ignagni S. Combined surgery and cryotherapy for melanoma of the conjunctiva: 37 months’ follow-up. Eur J Ophthalmol 1996;6(3):343−5.
(check this in PDF content)
7
Finger P.T., Czechonska G., Liarikos S. Topical mitomycin C chemotherapy for conjunctival melanoma and PAM with atypia. Br J Ophthalmol 1998;82:476−9.
(check this in PDF content)
8
Finger P.T., Sedeek R.W., Chin K.J. Topical interferon alfa in the treatment of conjunctival melanoma and primary acquired melanosis complex. Am J Ophthalmol 2008;145(1):124−9.
(check this in PDF content)
9
Finger P.T., Yu G.P. Conjunctival melanoma: is it increasing in the United States? Am J Ophthalmol 2003; 136:1190−1.
(check this in PDF content)
10
Nemunaitis J., Fong Т., Robbins J.M. et al. Phase I trial of interferon-gamma retroviral vector administered intratumorally to patients with metastatic melanoma. Cancer Gene Ther 1999;6:322−30.
(check this in PDF content)
11
Richtig E., Langmann G., Mullner K. et al. Ocular melanoma: epidemiology, clinical presentation and relationship with dysplastic nevi. Ophthalmologica 2004; 218:111−4.
(check this in PDF content)
12
Rodriguez-Ares T., Tourino R., De Rojas V. et al. Topical mitomycin C in the treatment of pigmented conjunctival lesions. Cornea 2003;22:114−7.
(check this in PDF content)
13
Seregard S. Conjunctival melanoma. Surv Ophthalmol 1998;42:321−50.
(check this in PDF content)
14
Seregard S., Paridaens A.D., Minassian D.C., et al. Prognostic factors in primary malignant melanoma of the conjunctiva: a clinicopathological study of 256 cases. Br J Ophthalmol 1994; 78:252−9.
(check this in PDF content)
15
Shields C.L., Shields J.A., Gunduz K. et al. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis and death in 150 consecutive patients. Arch Ophthalmol 2000;118:1497−507.
(check this in PDF content)
16
Stannard C.E., Sealy G.R.H., Hering E.R. et al. Malignant melanoma of the eyelid and palpebral conjunctiva treated with iodine-125 brachytherapy. Ophthalmology 2000;107:951−8.
(check this in PDF content)
17
Stratas B.A. Conjunctival melanoma: is it increasing in the United States? Am J Ophthalmol 2003;136:1190−1.
(check this in PDF content)
18
Tuomaala S., Kivela T. Conjunctival melanoma: is it increasing in the United States? Am J Ophthalmol 2003;136:1189−90.
(check this in PDF content)
19
Tuomaala S., Kivela T. Metastatic pattern and survival in disseminated conjunctival melanoma: implications for sentinel lymph node biopsy. Ophthalmology 2004;111:816−21.
(check this in PDF content)
20
Yu G.P., Hu D.N., McCormick S. et al. Conjunctival melanoma: is it increasing in the United States? Am J Ophthalmol 2003; 135:800−6.
(check this in PDF content)
21
Yuen V.H., Jordan D.R., Brownstein S. et al. Topical mitomycin treatment for primary acquired melanosis of the conjunctiva. Ophthalmic Plast Reconstr Surg 2003;19:149−51.
(check this in PDF content)